Cargando…
The role of cancer-derived microRNAs in cancer immune escape
During malignant transformation, accumulated somatic mutations endow cancer cells with increased invasiveness and immunogenicity. Under selective pressure, these highly immunogenic cancer cells develop multiple strategies to evade immune attack. It has been well established that cancer cells could d...
Autores principales: | Yi, Ming, Xu, Linping, Jiao, Ying, Luo, Suxia, Li, Anping, Wu, Kongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103070/ https://www.ncbi.nlm.nih.gov/pubmed/32222150 http://dx.doi.org/10.1186/s13045-020-00848-8 |
Ejemplares similares
-
RDGN-based predictive model for the prognosis of breast cancer
por: Dong, Bing, et al.
Publicado: (2020) -
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
por: Yi, Ming, et al.
Publicado: (2021) -
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
por: Qin, Shuang, et al.
Publicado: (2019) -
The roles of exosomes in cancer drug resistance and its therapeutic application
por: Li, Shiyu, et al.
Publicado: (2020) -
LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs
por: Xia, Rongmu, et al.
Publicado: (2021)